Moderna Inc. (MRNA) Live Share Price, Invest From India

Moderna Inc. Stock Performance

as on July 31, 2026 at 2:15 pm IST

Day's Low
Day's High
$54.52
Day's Price Range
$58.07
$57.92
5.87%
Downside
0.26%
Upside
52 Week's Low
52 Week's High
$22.28
52-Week Price Range
$85.60
$57.92
61.53%
Downside
47.79%
Upside

Moderna Inc. share price movements today

Previous Close: $54.49
Open: $55.88
Volume: 3.0M
Day's Low - High: $54.52 - $58.07
52 Week Low - High: $22.28 - $85.60

Moderna Inc. Historical Returns

1 Month Return: -24.84 %
3 Month Return: + 20.1 %
1 Year Return: + 84.34 %
3 Year Return: -53.69 %
5 Year Return: -84.59 %

Moderna Inc. Stock Fundamentals & Key Indicators

Check Moderna Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.1B

EPS (TTM)

-8.6657

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

-143.55%

Return On Equity TTM

-36.56%

Moderna Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moderna Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Moderna Inc.	BUY	$22.1B	-84.59%	NA	-143.55%	NA
Revolution Medicines Inc.	BUY	$39.1B	531.7%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$124.5B	139.77%	28.41	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$72.9B	21.02%	16.29	29.65%	0.54%

Stock Returns calculator for Moderna Inc. Stock including INR - Dollar returns

The Moderna Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Moderna Inc. investment value today

Current value as on today

₹2,13,529

Returns

₹1,13,529

(+113.53%)

Returns from Moderna Inc. Stock

₹95,940 (+95.94%)

Dollar Impact

₹17,588 (+17.59%)

Analyst Recommendation on Moderna Inc. Stock

Based on 31 analysts

BUY

54.84%

Buy

35.48%

Hold

9.68%

Sell

Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna Inc.. Average target price of $49.37

Moderna Inc. Share Price Target

Get share price movements and forecasts by analysts on Moderna Inc..

What analysts predicted

-17.32%DOWNSIDE

Target Price

$49.37

Current Price

$57.92

Analyzed by

31 Analysts

Target

$49.37

Moderna Inc. target price $49.37, a slight downside of -17.32% compared to current price of $57.92. According to 31 analysts rating.

Indian Investors' Interest in Moderna Inc. Stock

Investment in Moderna Inc. Shares on INDmoney has grown by 17.30% in the last 30 days, indicating increased investment activity.

Time period: July 1, 2026 to July 31, 2026

Change:17.30% versus previous 30 day period

Search interest for Moderna Inc. Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 1, 2026 to July 31, 2026

Change:11% versus previous 30 day period

Moderna Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2,813	167	221	1,855	956	107	142	1,016	678	389
Gross Profit	1,884	71	106	1,341	217	17	23	8	226	-566
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	217	-1,175	-1,279	13	-1,120	-971	-825	-200	-826	-1,343
Net Profit Margin	7.71%	-703.59%	-578.73%	0.70%	-117.15%	-907.48%	-580.99%	-19.69%	-121.83%	-345.24%

Moderna Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	108	205	122	48	274	17,736	18,875	6,848	3,199	1,944
Gross Profit	93	185	-331	48	266	15,119	13,459	2,155	1,735	1,076
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-216	-255	-384	-514	-747	12,202	8,362	-4,714	-3,561	-2,822
Net Profit Margin	-199.46%	-124.34%	-314.04%	-1070.07%	-272.16%	68.80%	44.30%	-68.84%	-111.32%	-145.16%

Mutual Funds that own Moderna Inc. Stock

Check out the Mutual Funds with significant holdings in Moderna Inc..

Funds	Holdings	Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth	0.03807%	2577

Global Institutional Holdings in Moderna Inc.

Funds	Holdings
Flagship Ventures Management, Inc.	1.17%
The Goldman Sachs Group Inc	1.66%
Amvescap Plc.	1.21%
Charles Schwab Investment Management Inc	1.19%
Vanguard Portfolio Management, LLC	3.94%

See all

Moderna Inc. News & Key Events

Today's Timeline - 29 July
Wed, 06:39 PM
-
Moderna secures EU approval for mCOMBRIAX, its first flu-COVID combo vaccine, enhancing its respiratory franchise.
Wed, 08:35 PM
-
Moderna reports significant Q1 revenue growth but faces a GAAP net loss of $1.3 billion due to legal costs.
Wed, 09:39 PM
-
Despite a 70.9% gain over the past year, Moderna stock appears overvalued amid ongoing legal uncertainties.
Today's Timeline - 29 July
Wed, 10:33 PM
-
Moderna to report Q2 earnings on July 31, with expected sales of $126.7 million and a loss of $1.97 per share.

Insights on Moderna Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, MRNA stock has moved up by 84.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 589.2% return, outperforming this stock by 642.9%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 385.4% return, outperforming this stock by 301.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 1.01B → 388.99M (in $), with an average decrease of 38.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -199.99M → -1.34B (in $), with an average decrease of 187.8% per quarter

About Moderna Inc.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Organisation	Moderna Inc.
Headquarters	325 Binney Street, Cambridge, MA, United States, 02142
Industry	Biotechnology
CEO	Mr. Stéphane Bancel M.B.A.
E-voting on shares	Click here to vote

Key Management of Moderna Inc.

Name	Title
Mr. Patrick Norman Bergstedt	Senior Vice President of Commercial Vaccines
Mr. Stéphane Bancel M.B.A.	CEO & Director
Mr. James M. Mock	Chief Financial Officer
Ms. Shannon Thyme Klinger J.D.	Chief Legal Officer & Corporate Secretary
Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer
Ms. Tracey Franklin	Chief People & Digital Technology Officer
Dr. Charbel Haber M.P.H., Ph.D.	Senior VP & Head of Global Regulatory Science
Dr. Stephen Hoge M.D.	President
Ms. Lavina Talukdar CFA	Senior VP & Head of Investor Relations
Chris Ridley	VP & Global Head of Communications

FAQs

What is Moderna Inc. share price today?

Moderna Inc. share price today is $57.92 as on July 31, 2026 at 8:45 am IST at the close of the market. Moderna Inc. share today touched a day high of $58.07 and a low of $54.52.

What is the 52 week high and 52 week low for Moderna Inc. share?

Moderna Inc. share touched a 52 week high of $85.60 on January 1, 1970 and a 52 week low of $22.28 on January 1, 1970. Moderna Inc. stock price today i.e. July 31, 2026 at 8:45 am IST is closed at $57.92,which is 32.34% down from its 52 week high and 159.96% up from its 52 week low.

What is Moderna Inc.'s market capitalisation today?

Moderna Inc. market capitalisation is $0.02T as on July 31, 2026 at 8:45 am IST.

How to invest in Moderna Inc. Stock (MRNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Moderna Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moderna Inc. Shares that will get you 0.0259 shares as per Moderna Inc. share price of $57.92 per share as on July 31, 2026 at 8:45 am IST.

What is the minimum amount required to buy Moderna Inc. Stock (MRNA) from India?

Indian investors can start investing in Moderna Inc. (MRNA) shares with as little as ₹95.38 or $1 (as of July 31, 2026 at 5:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Moderna Inc. stock (as per the Rupee-Dollar exchange rate as on July 31, 2026 at 5:39 pm IST). Based on Moderna Inc. share’s latest price of $57.92 as on July 31, 2026 at 8:45 am IST, you will get 0.1727 shares of Moderna Inc.. Learn more about fractional shares .

What are the returns that Moderna Inc. has given to Indian investors in the last 5 years?

Moderna Inc. stock has given -84.59% share price returns and 28.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Moderna Inc.